2 enrolling by invitation. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Enrolling by invitation 2 |
Follow Nervous System Neoplasms: new trials by email Literature Review of Nervous System Neoplasms trials Research Report on Nervous System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabergoline in the Management of Nonfunctioning Pituitary Adenoma Cabergoline 0.5 MG - Pituitary Adenoma, MRI | Phase 4 | Enrolling by invitation | National Taiwan University Hospital | 30 | 2024-05-20 | 2025-06-24 |
| Quality Improvement and Practice Based Research in Neurology Using the EMR Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description) - Brain Tumors, Epilepsy | Phase 4 | Enrolling by invitation | Endeavor Health | 3300 | 2016-05-01 | 2025-08-24 |
Brain Concussion (1) · Brain Neoplasms (1) · Cognitive Dysfunction (1) · Epilepsy (1) · Migraine Disorders (1) · Multiple Sclerosis (1) · Parkinson Disease (1) · Pituitary Neoplasms (1) · Restless Legs Syndrome (1) · Stroke (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Basal Ganglia Diseases (1) · Brain Injuries (1) · Brain Injuries, Traumatic (1) · Brain Neoplasms (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1)
Cabergoline (1)
Endeavor Health (1) · National Taiwan University Hospital (1)
Taiwan (1) · United States (1)